ScoreWhy is Fortress Biotech, Inc. ?
1
With a growth in Net Sales of 7.42%, the company declared Outstanding results in Sep 25
- NET PROFIT(Q) At USD 5.85 MM has Grown at 231.49%
- OPERATING CASH FLOW(Y) Highest at USD -15.14 MM
- ROCE(HY) Highest at 10.35%
2
High Institutional Holdings at 34.72%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
3
Market Beating Performance
- The stock has generated a return of 73.84% in the last 1 year, much higher than market (S&P 500) returns of 14.90%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Fortress Biotech, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fortress Biotech, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fortress Biotech, Inc.
73.84%
0.67
78.60%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.71%
EBIT Growth (5y)
1.56%
EBIT to Interest (avg)
-10.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
0.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.72%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.72
EV to EBIT
-0.70
EV to EBITDA
-0.76
EV to Capital Employed
2.59
EV to Sales
1.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-369.24%
ROE (Latest)
-101.83%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
NET PROFIT(Q)
At USD 5.85 MM has Grown at 231.49%
OPERATING CASH FLOW(Y)
Highest at USD -15.14 MM
ROCE(HY)
Highest at 10.35%
NET SALES(Q)
Highest at USD 17.63 MM
OPERATING PROFIT(Q)
Highest at USD -5.16 MM
OPERATING PROFIT MARGIN(Q)
Highest at -29.26 %
PRE-TAX PROFIT(Q)
Highest at USD 8.86 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Fortress Biotech, Inc.
Net Profit
At USD 5.85 MM has Grown at 231.49%
over average net sales of the previous four periods of USD -4.45 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Pre-Tax Profit
At USD 8.86 MM has Grown at 138.49%
over average net sales of the previous four periods of USD -23.01 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Operating Cash Flow
Highest at USD -15.14 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 17.63 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 17.63 MM has Grown at 18.93%
over average net sales of the previous four periods of USD 14.83 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD -5.16 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -29.26 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 8.86 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
